Amicus Therapeutics Inc (NASDAQ:FOLD)

10.97
Delayed Data
As of Mar 30
 +0.01 / +0.09%
Today’s Change
1.77
Today|||52-Week Range
13.20
+31.85%
Year-to-Date

Today’s Trading

Previous close10.96
Today’s open11.08
Day’s range-- - --
Volume1,222,591
Average volume (3 months)1,918,834
Market cap$1.0B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)+19.83%
Earnings growth (this year)-19.89%
Earnings growth (next 5 years)--
Revenue growth (last year)+237.19%
P/E ratioNM
Price/Sales506.03
Price/Book8.57

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...+0.15+3.46%
PRTAProthena Corporation...+1.53+4.04%
KPTIKaryopharm Therapeut...+1.17+3.93%
ARRYArray Biopharma Inc+0.14+1.89%
Data as of 03/30/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$1.2M
Annual profit (last year)-$68.9M
Net profit margin-5,631.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account